We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

33 hedge funds and large institutions have $867K invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

6% more funds holding

Funds holding: 3133 (+2)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

25% less capital invested

Capital invested by funds: $1.15M → $867K (-$283K)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$714K
LP
2
LMR Partners
United Kingdom
$127K +$615 +12,500 New
SCM
3
Saba Capital Management
New York
$4.3K
PC
4
Periscope Capital
Ontario, Canada
$2.92K +$7.01K +142,404 +33%
EFI
5
EHP Funds Inc
Canada
$2K -$3.42K -69,434 -15%
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$1.91K
SC
7
Sculptor Capital
New York
$1.63K -$49 -1,000 -0.5%
CCA
8
Castle Creek Arbitrage
Colorado
$1.53K +$14.8K +300,000 New
FBCM
9
Fort Baker Capital Management
California
$1.25K
LA
10
Linden Advisors
New York
$1.1K
PMAM
11
Picton Mahoney Asset Management
Ontario, Canada
$1K
SCM
12
Shaolin Capital Management
Florida
$1K
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$956
Goldman Sachs
14
Goldman Sachs
New York
$655
TCM
15
Tenor Capital Management
New York
$638
CSS
16
Cubist Systematic Strategies
Connecticut
$617
GAM
17
Gritstone Asset Management
Maryland
$587 +$5.67K +115,179 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$510
CH
19
CVI Holdings
Delaware
$440
WAM
20
Wolverine Asset Management
Illinois
$421
SG
21
StoneX Group
New York
$396 +$3.82K +77,723 New
AA
22
AQR Arbitrage
Connecticut
$387
SSA
23
Schonfeld Strategic Advisors
New York
$382 +$1.48K +29,982 +67%
Walleye Capital
24
Walleye Capital
New York
$177
SAMU
25
SONA Asset Management (US)
New York
$153

LVACW Hedge Fund Activity: Q4 2022 in Review

33 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q4 2022, worth a combined $867K — down 25% from $1.15M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new LVACW positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $14.8K. The largest seller was Basso Capital Management, exiting entirely with an estimated $8K sold.

  • 33 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q4 2022, up from 31 in Q3 2022.
  • Funds reported $867K of LAVA Medtech Acquisition Corp. Warrants stock for Q4 2022, down 25% quarter-over-quarter.
  • 5 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $14.8K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q4 2022 was Basso Capital Management, an estimated $8K sold.

Based on aggregated 13F filings for Q4 2022.